GoodRx Holdings Management

Management Kriterienprüfungen 2/4

GoodRx Holdings CEO ist Scott Wagner , ernannt in Apr 2023, hat eine Amtszeit von 1.58 Jahren. Die jährliche Gesamtvergütung beträgt $10.14M , bestehend aus 5% Gehalt und 95% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.11% der Aktien des Unternehmens, im Wert von $1.97M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.5 Jahre bzw. 7.3 Jahre.

Wichtige Informationen

Scott Wagner

Geschäftsführender

US$10.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts5.0%
Amtszeit als Geschäftsführer1.6yrs
Eigentum des Geschäftsführers0.1%
Durchschnittliche Amtszeit des Managements2.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder7.3yrs

Jüngste Management Updates

Recent updates

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

Oct 29
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)

Oct 26

GoodRx Holdings: Failing To Gain Much Traction

Oct 08

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

GoodRx: Encouraging Profit Stabilization (Rating Upgrade)

May 28

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Scott Wagner im Vergleich zu den Einnahmen von GoodRx Holdings verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$59m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$10mUS$512k

-US$9m

Vergütung im Vergleich zum Markt: ScottDie Gesamtvergütung ($USD10.14M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD5.33M).

Entschädigung vs. Einkommen: Unzureichende Daten, um die Vergütung von Scott mit der Unternehmensleistung zu vergleichen.


Geschäftsführer

Scott Wagner (53 yo)

1.6yrs

Amtszeit

US$10,144,526

Vergütung

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.42%
$ 26.4m
Scott Wagner
Interim CEO & Principal Operating Officer1.6yrsUS$10.14m0.11%
$ 2.0m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.42%
$ 26.4m
Karsten Voermann
Chief Financial Officer4.7yrsUS$902.24k0.072%
$ 1.3m
Romin Nabiey
Chief Accounting Officer2.6yrsUS$2.58m0.020%
$ 363.3k
Bansi Nagji
President of Healthcare4.4yrsUS$4.91m0.065%
$ 1.2m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a yearkeine Datenkeine Daten
Nitin Shingate
Chief Technology Officer1.9yrskeine Datenkeine Daten
Aubrey Reynolds
Director of Investor Relationsno datakeine Datenkeine Daten
Gracye Cheng
General Counsel & Secretaryno datakeine Datenkeine Daten
Andrew Slutsky
Chief Marketing Officer1.3yrsUS$864.80k0%
$ 0
Vina Leite
Chief People Officer2.5yrskeine Datenkeine Daten

2.5yrs

Durchschnittliche Betriebszugehörigkeit

53yo

Durchschnittliches Alter

Erfahrenes Management: GDRXDas Führungsteam des Unternehmens gilt als erfahren (2.5 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.42%
$ 26.4m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.42%
$ 26.4m
Gregory Mondre
Independent Director6.1yrskeine Datenkeine Daten
Dipanjan Deb
Independent Director9.1yrskeine Datenkeine Daten
Ian T. Clark
Directorless than a yearkeine Datenkeine Daten
Agnes Rey-Giraud
Independent Director8.4yrsUS$269.53k0.079%
$ 1.5m
Christopher Adams
Independent Director9.1yrskeine Datenkeine Daten
Simon Patterson
Directorless than a yearkeine Datenkeine Daten
Kelly Kennedy
Independent Directorless than a yearUS$448.63kkeine Daten
Ronald Bruehlman
Directorno datakeine Datenkeine Daten

7.3yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrener Vorstand: GDRXDie Vorstandsmitglieder gelten als erfahren (7.3 Jahre durchschnittliche Amtszeit).